From the event organizer:
“This symposium will provide insight into the changing landscape of pharmaceutical development and healthcare innovation. Presenters will describe available resources in Southeast Wisconsin to help researchers develop and commercialize drug leads two different ways, via licensing or the formation of a spinout company. Plenary and breakout sessions will bring together academic investigators and experts in the area of drug development and commercialization. The symposium’s topics will include intellectual property protection, the formation of biotechnology startups, funding strategies and financial models, and building strong partnerships.”
Speakers include Dohmen CEO Cynthia LaConte; Eric Olson, chief scientific officer at Syros and former director of the cystic fibrosis program at Vertex; and John Neis, managing director of Venture Investors.
For more information and to register, click here.